Church TR, Black WC, Aberle DR et al (2013) Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 368(21):1980–1991

Article  PubMed  Google Scholar 

Memon D, Schoenfeld AJ, Ye D et al (2024) Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer. Cancer Cell 42(2):209-224.e209

Article  PubMed  PubMed Central  CAS  Google Scholar 

Xie S, Gao Z, Zhang W et al (2024) Research progress in mechanisms of acquired drug resistance and EGFR-targeted therapy tolerance in non-small cell lung cancer. Chin J Pharmacovigilance 21(214):1081–1086

Google Scholar 

Chinese Society of Oncology: Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2024 edition). 2024(34(104)):3175–3213.

Yan Z, Chen B, Yang Y et al (2022) Multi-omics analyses of airway host-microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions. Nat Microbiol 7(9):1361–1375

Article  PubMed  CAS  Google Scholar 

Aggarwal N, Kitano S, Puah GRY et al (2023) Microbiome and human health: current understanding, engineering, and enabling technologies. Chem Rev 123(1):31–72

Article  PubMed  CAS  Google Scholar 

Tang Y et al (2024) Gut microbes improve prognosis of Klebsiella pneumoniae pulmonary infection through the lung-gut axis. Front Cell Infect Microbiol 14:1392376

Article  PubMed  PubMed Central  Google Scholar 

Budden KF et al (2024) Faecal microbial transfer and complex carbohydrates mediate protection against COPD. Gut 73(5):751–769

Article  PubMed  CAS  Google Scholar 

Jin Y et al (2019) The diversity of gut microbiome is associated with favorable responses to anti-programmed death 1 immunotherapy in Chinese patients with NSCLC. J Thorac Oncol 14(8):1378–1389

Article  PubMed  CAS  Google Scholar 

Tsay JJ, Wu BG, Sulaiman I et al (2021) Lower airway dysbiosis affects lung cancer progression. Cancer Discov 11(2):293–307

Article  PubMed  CAS  Google Scholar 

Belaid A, Roméo B, Rignol G et al (2024) Impact of the lung microbiota on development and progression of lung cancer. Cancers (Basel). https://doi.org/10.3390/cancers16193342

Article  PubMed  Google Scholar 

Boesch M, Baty F, Albrich WC et al (2021) Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer. Oncoimmunology 10(1):1988403

Article  PubMed  PubMed Central  Google Scholar 

Sommariva M, Le Noci V, Bianchi F et al (2020) The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy. Cell Mol Life Sci 77(14):2739–2749

Article  PubMed  PubMed Central  CAS  Google Scholar 

Greathouse KL, White JR, Vargas AJ et al (2018) Interaction between the microbiome and TP53 in human lung cancer. Genome Biol 19(1):123

Article  PubMed  PubMed Central  Google Scholar 

Li X, Liang Y, Tu H (2023) Research progress of the intratumoral microbiome. China Oncol 33(9):866–873

CAS  Google Scholar 

Fu A, Yao B, Dong T et al (2023) Emerging roles of intratumor microbiota in cancer metastasis. Trends Cell Biol 33(7):583–593

Article  PubMed  CAS  Google Scholar 

Cao Y, Xia H, Tan X et al (2024) Intratumoural microbiota: a new frontier in cancer development and therapy. Signal Transduct Target Ther 9(1):15

Article  PubMed  PubMed Central  Google Scholar 

Liu W, Xu J, Pi Z et al (2023) Untangling the web of intratumor microbiota in lung cancer. Biochim Biophys Acta Rev Cancer 1878(6):189025

Article  PubMed  CAS  Google Scholar 

Apopa PL, Alley L, Penney RB et al (2018) PARP1 is up-regulated in non-small cell lung cancer tissues in the presence of the cyanobacterial toxin microcystin. Front Microbiol 9:1757

Article  PubMed  PubMed Central  Google Scholar 

Dohlman AB, Klug J, Mesko M et al (2022) A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors. Cell 185(20):3807-3822.e3812

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu NN, Yi CX, Wei LQ et al (2023) The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells. Cancer Cell 41(11):1927-1944.e1929

Article  PubMed  CAS  Google Scholar 

Ma Y, Chen H, Li H et al (2024) Intratumor microbiome-derived butyrate promotes lung cancer metastasis. Cell Rep Med 5(4):101488

Article  PubMed  PubMed Central  CAS  Google Scholar 

Stasiewicz M, Karpiński TM (2022) The oral microbiota and its role in carcinogenesis. Semin Cancer Biol 86(Pt 3):633–642

Article  PubMed  CAS  Google Scholar 

Hosgood HD, Cai Q, Hua X et al (2021) Variation in oral microbiome is associated with future risk of lung cancer among never-smokers. Thorax 76(3):256–263

Article  PubMed  Google Scholar 

Zhang K, He C, Qiu Y et al (2023) Association of oral microbiota and periodontal disease with lung cancer: a systematic review and meta-analysis. J Evid Based Dent Pract 23(3):101897

Article  PubMed  Google Scholar 

Reddy RM, Lagisetty K, Lin J et al (2024) Comprehensive sampling of the lung microbiome in early-stage non-small cell lung cancer. JTCVS Open 17:260–268

Article  PubMed  Google Scholar 

Jin J, Gan Y, Liu H et al (2019) Diminishing microbiome richness and distinction in the lower respiratory tract of lung cancer patients: a multiple comparative study design with independent validation. Lung Cancer 136:129–135

Article  PubMed  Google Scholar 

Leng Q, Holden VK, Deepak J et al (2021) Microbiota biomarkers for lung cancer. Diagnostics. https://doi.org/10.3390/diagnostics11030407

Article  PubMed  PubMed Central  Google Scholar 

Liu B, Li Y, Suo L et al (2022) Characterizing microbiota and metabolomics analysis to identify candidate biomarkers in lung cancer. Front Oncol 12:1058436

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cheng C, Wang Z, Wang J et al (2020) Characterization of the lung microbiome and exploration of potential bacterial biomarkers for lung cancer. Transl Lung Cancer Res 9(3):693–704

Article  PubMed  PubMed Central  CAS  Google Scholar 

McLean AEB, Kao SC, Barnes DJ et al (2022) The emerging role of the lung microbiome and its importance in non-small cell lung cancer diagnosis and treatment. Lung Cancer 165:124–132

Article  PubMed  CAS  Google Scholar 

Man Y (2019) Lung microbiome in advanced non-small cell lung cancer and its relationship with prognosis. Master’s Thesis.

Wang X, Xiao T, Lu M et al (2024) Lower respiratory tract microbiome and lung cancer risk prediction in patients with diffuse lung parenchymal lesions. Front Cell Infect Microbiol 14:1410681